12-Month Lobbying Summary - Consultant

Details Regarding the Identified Subject Matter

Subject matters	Details	Categories
Health	Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries	Policies or Program
Health	Food and Drug Regulations with respect to Data Protection under. C.08.004	Regulation
Health	Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products	Policies or Program
Health	Health Canada Health Products & Food Regulatory Modernization	Policies or Program
Economic Development, Industry, Intellectual Property, Research and Development, Science and Technology	Innovation Agenda led by Innovation, Science and Economic Development Canada, particularly with respect to the life sciences sector	Policies or Program
Health	Medical Devices Regulations under the Food and Drugs Act, specifically with respect to the approval, regulation and life cycle management of medical devices	Regulation
Health, Intellectual Property	Patent Act as it relates to the regulation of intellectual property for therapeutic products	Policies or Program
Health, Intellectual Property	Patent Act regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations	Regulation
Health, Intellectual Property	Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)	Policies or Program
Health	Patented Medicine Prices Review Board with respect to regulations of reporting obligations of patentees	Policies or Program
Health	Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products	Policies or Program
Health, International Trade	Proposed and potential policies with respect to current or potential regulation of cross-border trade in pharmaceuticals, including the Export Control List	Policies or Program

• Subject matter details in previous versions

  Details Regarding the Identified Subject Matter

  Subject matters	Details	Categories
  Subject matters were not required to be associated with subject matter details when this content was submitted	Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Food and Drug Regulations with respect to Data Protection under. C.08.004	Regulation
  Subject matters were not required to be associated with subject matter details when this content was submitted	Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Health Canada Health Products & Food Regulatory Modernization	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Innovation Agenda led by Innovation, Science and Economic Development Canada, particularly with respect to the life sciences sector	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Medical Devices Regulations under the Food and Drugs Act, specifically with respect to the approval, regulation and life cycle management of medical devices	Regulation
  Subject matters were not required to be associated with subject matter details when this content was submitted	Patent Act as it relates to the regulation of intellectual property for therapeutic products	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Patent Act regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations	Regulation
  Subject matters were not required to be associated with subject matter details when this content was submitted	Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Patented Medicine Prices Review Board with respect to regulations of reporting obligations of patentees	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Policies or programs with respect to Federal Public Drug Benefit Programs	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Proposed and potential policies with respect to current or potential regulation of cross-border trade in pharmaceuticals, including the Export Control List	Policies or Program

  Subject matters in previous versions

  • Consumer Issues
  • Health
  • Industry
  • Intellectual Property
  • International Trade
  • Research and Development
  • Science and Technology
  • Taxation and Finance

Government Institutions

• Finance Canada (FIN)
• Global Affairs Canada (GAC)
• Health Canada (HC)
• House of Commons
• Innovation, Science and Economic Development Canada (ISED)
• Justice Canada (JC)
• Patented Medicine Prices Review Board (PMPRB)
• Prime Minister's Office (PMO)
• Senate of Canada

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

• Oral communication
• Written communication
• Arrange one or more meetings

Stephen Sampson, Consultant (Business address and contact information)

Public offices held